Pronova Gets 2.28 Billion Kronor of Syndicated Loans

Pronova BioPharma ASA, the Norwegian maker of medicines from fish oil, got 2.28 billion kronor ($393 million) of syndicated loans from three banks.

Nordea Bank AB arranged the multicurrency financing, which includes term loans and a revolving credit line, the bank said in a statement. Money in a revolving credit can be borrowed again once it’s been repaid.

SEB AB and Swedbank AB joined the deal in syndication, according to the statement.

Proceeds of the five-year financing replace existing borrowings maturing in 2012, Lysaker, Norway-based Pronova said Oct. 4 in a statement.

To contact the reporter on this story: Karen Eeuwens in London

To contact the editor responsible for this story: Faris Khan at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.